长期住院ICU患者的衰弱:6个月死亡与恢复结局
这项回顾性队列研究纳入2018年5月至2021年5月ICU住院≥7天的531例患者,按入院临床衰弱量表(CFS)分为衰弱(CFS≥5,178例,33.6%)、衰弱前期(CFS 3-4,200例,37.6%)和非衰弱(CFS 1-2,153例,28.8%)。6个月时衰弱组死亡率34.3%(61/178),高于衰弱前期组21%(42/200)和非衰弱组13.1%(20/153)(p<0.01)。以CFS 1-2为参照,6个月死亡的校正HR为CFS 3-4 1.7(95%CI 0.9-2.9)、CFS≥5 2.9(95%CI 1.7-4.9)。192例完成随访评估,CFS≥5与较差的躯体健康相关生活质量相关,与心理卫生健康相关生活质量无关。
要点
- 长期住院ICU患者中,入院CFS≥5的衰弱者6个月死亡率为34.3%(61/178),高于衰弱前期21%(42/200)和非衰弱13.1%(20/153)(p<0.01)。
- 以CFS 1-2为参照,6个月死亡的校正HR为CFS 3-4 1.7(95%CI 0.9-2.9),CFS≥5 2.9(95%CI 1.7-4.9)。
- 三组之间撤除或限制治疗的比例无显著差异。
- 6个月随访的192例中,CFS≥5与较差的躯体健康相关生活质量相关,但与心理卫生健康相关生活质量无关。
- 入院CFS有助于告知患者及家属长期ICU幸存者可能面临的复杂结局。
适用人群与场景
- 2018年5月至2021年5月在ICU住院≥7天的患者,随访至6个月或死亡。
- 按入院时临床衰弱量表(CFS)分为衰弱(CFS≥5)、衰弱前期(CFS 3-4)和非衰弱(CFS 1-2)。
诊断标准与关键阈值
- 使用入院时临床衰弱量表(CFS)评估:衰弱为CFS≥5,衰弱前期为CFS 3-4,非衰弱为CFS 1-2。
研究设计与关键结果
- 回顾性队列研究纳入531例ICU住院≥7天患者,衰弱组178例(33.6%)、衰弱前期组200例(37.6%)、非衰弱组153例(28.8%)。
- 衰弱患者年龄更大、合并症更多、入ICU时疾病严重程度更高。
- 6个月死亡率:衰弱组34.3%(61/178) vs 衰弱前期组21%(42/200) vs 非衰弱组13.1%(20/153),p<0.01。
- 撤除或限制治疗的比例在三组间无显著差异。
- 以CFS 1-2为参照,6个月死亡的校正HR:CFS 3-4为1.7(95%CI 0.9-2.9),CFS≥5为2.9(95%CI 1.7-4.9)。
- 6个月时192例患者接受随访评估;多因素线性回归显示,与CFS 1-2相比,CFS≥5与较差的躯体健康相关生活质量相关,与心理卫生健康相关生活质量无关。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,入院CFS可帮助告知患者及家属长期ICU住院幸存者结局的复杂性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Prolonged intensive care unit (ICU) stay is associated with physical, cognitive, and psychological disabilities. The impact of baseline frailty on long-stay ICU patients remains uncertain. This study aims to investigate how baseline frailty influences mortality and post-ICU disability 6 months after critical illness in long-stay ICU patients.
METHODS: In this retrospective cohort study, we assessed patients hospitalized for ≥ 7 days in the ICU between May 2018 and May 2021, following them for up to 6 months or until death. Based on the Clinical Frailty Scale (CFS) at ICU admissions, patients were categorized as frail (CFS ≥ 5), pre-frail (CFS 3-4) and non-frail (CFS 1-2). Kaplan-Meier curves and a multivariate Cox model were used to examine the association between frailty and mortality. At the 6 month follow-up, we assessed psychological, physical, cognitive outcomes, and health-related quality of life (QoL) using descriptive statistics and linear regressions.
RESULTS: We enrolled 531 patients, of which 178 (33.6%) were frail, 200 (37.6%) pre-frail and 153 (28.8%) non-frail. Frail patients were older, had more comorbidities, and greater disease severity at ICU admission. At 6 months, frail patients presented higher mortality rates than pre-frail and non-frail patients (34.3% (61/178) vs. 21% (42/200) vs. 13.1% (20/153) respectively, p < 0.01). The rate of withdrawing or withholding of care did not differ significantly between the groups. Compared with CFS 1-2, the adjusted hazard ratios of death at 6 months were 1.7 (95% CI 0.9-2.9) for CFS 3-4 and 2.9 (95% CI 1.7-4.9) for CFS ≥ 5. At 6 months, 192 patients were seen at a follow-up consultation. In multivariate linear regressions, CFS ≥ 5 was associated with poorer physical health-related QoL, but not with poorer mental health-related QoL, compared with CFS 1-2.
CONCLUSION: Frailty is associated with increased mortality and poorer physical health-related QoL in long-stay ICU patients at 6 months. The admission CFS can help inform patients and families about the complexities of survivorship during a prolonged ICU stay.
参考来源
- Wozniak H, Beckmann TS, Dos Santos Rocha A, et al. Long-stay ICU patients with frailty: mortality and recovery outcomes at 6 months. Ann Intensive Care. 2024. PMID: 38401034. doi:10.1186/s13613-024-01261-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。